Brooklyn Investment Group’s MaxCyte MXCT Stock Holding History

Brooklyn Investment Group’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-81,270	Closed	-$179K	–	1538
2025 Q3	$179K	Sell	81,270 -7,500	-8%	-$13K	0.02%	606
2025 Q2	$194K	Buy	+88,770	New	+$215K	0.03%	631
2025 Q1	–	Sell	-409	Closed	-$1.7K	–	2844
2024 Q4	$1.7K	Buy	+409	New	+$1.55K	﹤0.01%	1504

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brooklyn Investment Group's MXCT Position: Q4 2025 in Review

Brooklyn Investment Group sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 81,270 shares — an estimated $179K sold.

Brooklyn Investment Group first reported a position in MXCT in Q4 2024 and held it in 3 quarters. The position peaked at $194K in Q2 2025. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

Brooklyn Investment Group reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
Brooklyn Investment Group sold 81,270 MaxCyte shares in Q4 2025, an estimated $179K.
Brooklyn Investment Group first reported a position in MaxCyte in Q4 2024 and held it in 3 quarters.
Brooklyn Investment Group's MaxCyte position peaked at $194K in Q2 2025.
112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on Brooklyn Investment Group's 13F filing for Q4 2025, filed 12 Feb 2026.